Summary
Objective
Polyamines are indispensable polycations and play important physiological roles in living cells. Some polyamine metabolites have been associated with autoimmune disorders. The aims of this study were to profile polyamine metabolites in autoimmune thyroid disease (AITD) and predict whether polyamine metabolites are associated with thyroid hormone, thyroid autoantibodies or disease progression.
Design, patients and measurements
A total of 136 participants were recruited, including Graves' disease (GD) (n=36), Hashimoto's thyroiditis (HT) (n=33) and thyroid autoantibody‐positive (pTAb) (n=29) patients and 38 age‐ and sex‐matched healthy controls (HCs). Fourteen polyamine metabolites, including polyamine precursors, polyamines and polyamine catabolite, were measured by UFLC‐MS/MS.
Results
Both GD and HT patients had higher L‐arginine, L‐ornithine, lysine and agmatine levels and lower putrescine, 1,3‐diaminopropane, spermine, N‐acetylputrescine levels than HCs. Some polyamine metabolite levels were different only in GD or HT patients compared to HCs: GD patients had significantly higher spermidine, N‐acetylspermidine and γ‐aminobutyric acid and lower cadaverine, whereas HT patients had significantly decreased N‐acetylspermine. Only spermine and N‐acetylspermine were significantly lower in pTAb than HCs. The spermine:spermidine ratio was significantly reduced in all AITD patients. In addition, spermine was negatively correlated with thyroid‐specific antibodies grade. N‐acetylspermidine might be a risk factor for pTAb progression to overt hypothyroidism.
Conclusions
Compared with the HCs, most metabolites of GD and HT showed similar patterns, suggesting the possibility of a common pathophysiological basis or metabolic pathway. Moreover, pTAb progression to overt hypothyroidism may be related to high N‐acetylspermidine. Thyroid autoimmunity was associated with low spermine.
This article is protected by copyright. All rights reserved.
http://bit.ly/2DfpvqD
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου